USA
 Dr. Vishal Singh (left), Crohn’s and Colitis Foundation Fellow, and Dr. Matam Vijay-Kumar (right), Associate Professor at the Dept. of Physiology and Pharmacology, College of Medicine, The University of Toledo, OH, USA. The current and future research goals of this group is directed toward preclinical studies that can be used translationally to develop dietary fiber-based therapies for liver diseases and intestinal inflammation. Drs. Singh and Vijay-Kumar envision that not all fibers are created equally, nor will they be fermented uniformly by the gut bacteria. Dr. Singh has published more than 40 research papers in peer-reviewed scientific journals and serves as a reviewer for many international journals. Dr. Vijay-Kumar has published more than 70 articles in peer-reviewed scientific journals. He is Director of the University of Toledo-Microbiome Consortium (UT-MiCo) and serving as editor and reviewer for many international journals and grant agencies. |
Dr. Karen Madsen is a Professor of Medicine at the University of Alberta and Director of the Centre of Excellence for Gastrointestinal Inflammation and Immunity Research (CEGIIR). She specializes in studying the gut microbiome's role in health and disease, focusing on therapies for inflammatory bowel disease and metabolic disorders. Dr. Madsen has published over 150 research papers and received multiple awards for her contributions to medical research and education. You can follow her on X at @madsen_ca.
Professor Everard is a senior researcher from the Belgian Fund for Scientific Research (FRS-FNRS-WEL Research Institute). She is leading a team at the Louvain Drug Research Institute (LDRI) from the University of Louvain (UCLouvain), Brussels, Belgium. The main topic of interest of her team in research is to study how gut microbes are able to impact eating behaviours. More specifically, she is investigating the interactions between the gut microbiota, the intestine and the brain in the context of obesity and eating disorders.